https://investor.ironwoodpharma.com/press-releases/press-release-details/2017/Astellas-and-Ironwood-Report-Positive-Top-Line-Results-from-Phase-III-Linaclotide-Trial-for-Patients-with-Chronic-Constipation-Conducted-in-Japan/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- January 29, 2017